Reversal of the anti-platelet effects of aspirin and clopidogrel
about
Hemostatic management of patients undergoing ear-nose-throat surgeryManagement of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentratesClopidogrel and hip fractures, is it safe? A systematic review and meta-analysisAlternatives to allogeneic platelet transfusion.Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementationPerioperative management of patients on chronic antithrombotic therapyAdvances in monitoring of aspirin therapy.Algorithm for anticoagulation management in geriatric hip fracture patients--Surgeons save Blood.Platelet function inhibitors and platelet function testing in neurointerventional procedures.Risk of bleeding associated with interventional musculoskeletal radiology procedures. A comprehensive review of the literature.Influence of acetylsalicylic acid and low-molecular weight heparins on the formation of renal hematoma after shock wave lithotripsy.Oral antiplatelet therapy: impact for transfusion medicine.The aspirin story - from willow to wonder drug.Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects.Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study.Platelet transfusion to reverse antiplatelet therapy before decompressive surgery in patients with intracranial haemorrhage.Peri-operative management of anticoagulation and antiplatelet therapy.Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model.Postoperative haemorrhage in powered endoscopic dacryocystorhinostomy.Relationship between pharmacokinetics and pharmacodynamics of clopidogrel in patients undergoing percutaneous coronary intervention: comparison between vasodilator-stimulated phosphoprotein phosphorylation assay and multiple electrode aggregometry.
P2860
Q26771864-FFB0CFC8-2FB2-4CC2-9AF8-003989F0CF7EQ26822974-DCC1C28D-1BAF-4D47-87A0-CE781027B64FQ28068229-7F1FD1CF-4687-46BB-B331-A8960EA6239FQ33435484-15751249-5BB6-42FC-834F-39F6DDDCC2D3Q36715385-93F07D5A-A9EA-4D50-B471-DAAC1EA1FC74Q36842832-B705E5F3-FE21-47D5-BAF0-4AB7EE8FD5DEQ38032895-356DFB2F-DA0D-4595-8715-6DE2B29A281AQ38195191-961D5F05-F206-4EDA-8A64-33B4F873EFD0Q38233284-4F80BCD2-2C86-4407-A58D-917CD5793536Q38272660-14F77C30-CCB1-47DD-938E-33FBD6F9D682Q38374050-32D21A38-F045-44D6-A9BD-79C036612C5BQ38754884-425DF29A-B837-4B2C-816D-945BD2CEF875Q38768065-73516DDB-6C28-48AB-BE05-87455704118CQ39366233-F6E9CF62-BCD8-4613-A4C9-97E9E8BEF4EFQ41023511-C2952289-F567-4B26-9F93-3EEC029F34ABQ48238106-216B2D1A-386C-492B-80AF-8548CC5C4904Q48316287-5E7678E4-293E-4641-9D06-31A99F3C980FQ48686943-60207390-1706-4507-80A6-2FC82BC6CA30Q51225347-B039BDB9-9702-4F43-8CD9-40BFECDFC38FQ52902317-DF6B521F-3CB9-47AF-A57A-E807D5045D1D
P2860
Reversal of the anti-platelet effects of aspirin and clopidogrel
description
article
@en
im März 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2012
@uk
name
Reversal of the anti-platelet effects of aspirin and clopidogrel
@en
Reversal of the anti-platelet effects of aspirin and clopidogrel
@nl
type
label
Reversal of the anti-platelet effects of aspirin and clopidogrel
@en
Reversal of the anti-platelet effects of aspirin and clopidogrel
@nl
prefLabel
Reversal of the anti-platelet effects of aspirin and clopidogrel
@en
Reversal of the anti-platelet effects of aspirin and clopidogrel
@nl
P2093
P2860
P1476
Reversal of the anti-platelet effects of aspirin and clopidogrel
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2012.04641.X
P577
2012-04-01T00:00:00Z